Overview

Lifecore Biomedical is a fully integrated Contract Development and Manufacturing Organization (CDMO) offering expertise in specialty formulation, aseptic filling, and final packaging of both complex medical devices and injectable pharmaceuticals. We currently manufacture FDA-approved commercial products at our three cGMP facilities and have received numerous certifications from regulators in Europe, Japan, and Brazil as well as the International Organization for Standardization (ISO).

Lifecore has also been a leading manufacturer of pharmaceutical-grade, non-animal-sourced hyaluronic acid (HA) since 1981 when we developed our proprietary, fermentation-based HA process. Since then, we have become the preferred viscoelastic supplier to ophthalmic market leaders and our products have been used in the treatment of more than 100 million patients worldwide.

For decades, Lifecore’s commitment to customers has enabled our success and allowed us to expand our infrastructure, increasing capacity to help support growing demands from the global pharmaceutical market.

Stock Information

Minimum 15 minutes delayed. Source:

Press Releases

12 Nov '24
CHASKA, Minn. , Nov. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that Paul Josephs , the company’s president and chief executive officer, will be a featured
04 Nov '24
Brings Strong Background in Pharmaceutical Manufacturing Operations and Finance to Help Drive Performance and Productivity Jackie Klecker Named Executive Vice President, Quality and Development Services to Focus on Sustaining Company’s Strong Regulatory and Compliance Track Record   Personnel Moves

Recent Events